SeaWorld Orlando has introduced a new character to its Halloween lineup. Howl-O-Scream visitors will be able to encounter ...
Werewolf Therapeutics (HOWL) stock surged 127% premarket after unveiling Ambros merger, $150M capital raise, and $33M EMD ...
US cancer care biotech Werewolf Therapeutics and Ambros Therapeutics today announced that they entered into a definitive ...
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) et Ambros Therapeutics, Inc. (NASDAQ:AMBX) ont annoncé vendredi qu'ils avaient convenu de fusionner dans le ...
Werewolf Therapeutics, Inc. (NASDAQ:HOWL) a été l'un des plus gros movers sur le marché avant l'ouverture vendredi après avoir annoncé une fusion ...
Werewolf Therapeutics, Inc. HOWL and Ambros Therapeutics, Inc. announced Friday that they agreed to merge in an all-stock ...
The new coaster will feature four launches, 32 airtime moments and more than 4,000 feet of track when it opens in 2027.
Werewolf Therapeutics Inc (NASDAQ:HOWL) shares soared 120% in premarket trading on Friday after the biotechnology company agreed to merge with Ambros Therapeutics Inc alongside a $150 million private ...
The stock is still priced like a distressed biotech, but the deal structure (institutional-backed financing + merger) should ...
SeaWorld Orlando is going bigger — and scarier — for Howl-O-Scream this year, with its largest Halloween event yet.
Werewolf Therapeutics (HOWL) and Ambros Therapeutics entered into an all-stock merger agreement to create a Nasdaq-listed biotech focused on developing neridronate for complex regional pain syndrome ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results